Zhejiang East Asia Pharmaceutical Co., Ltd. (SHA:605177)

China · Delayed Price · Currency is CNY

21.72

+0.19 (0.88%)

Feb 13, 2026, 3:00 PM CST

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Beta-lactam Antibiotics	793.09M
Beta-lactam Antibiotics Growth	-18.73%
Anticholinergic and Synthetic Antispasmodics	178.22M
Anticholinergic and Synthetic Antispasmodics Growth	11.61%
Quinolone Antibacterial Drugs	114.44M
Quinolone Antibacterial Drugs Growth	17.90%
Antifungals for Skin Use	69.56M
Antifungals for Skin Use Growth	-9.71%
Other Business	9.76M
Other Business Growth	66.65%
Other	33.17M
Other Growth	-18.90%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
China	979.38M
China Growth	-15.80%
Overseas	209.10M
Overseas Growth	11.55%